VestGen Advisors LLC Sells 2,405 Shares of Intuitive Surgical, Inc. $ISRG

VestGen Advisors LLC lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,667 shares of the medical equipment provider’s stock after selling 2,405 shares during the period. VestGen Advisors LLC’s holdings in Intuitive Surgical were worth $3,080,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in ISRG. Norges Bank purchased a new position in Intuitive Surgical during the 2nd quarter valued at about $2,569,260,000. Nuveen LLC bought a new position in shares of Intuitive Surgical during the first quarter valued at approximately $1,715,899,000. Vanguard Group Inc. increased its holdings in Intuitive Surgical by 2.1% during the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after buying an additional 670,302 shares during the period. Goldman Sachs Group Inc. increased its holdings in Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock valued at $1,396,496,000 after buying an additional 584,375 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Intuitive Surgical by 20.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after buying an additional 566,979 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Royal Bank Of Canada set a $625.00 price target on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. The Goldman Sachs Group raised their price objective on Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Piper Sandler raised their target price on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Finally, Argus upped their price target on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Trading Down 0.2%

NASDAQ:ISRG opened at $573.32 on Monday. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The firm has a fifty day simple moving average of $505.94 and a 200-day simple moving average of $504.62. The company has a market capitalization of $205.52 billion, a P/E ratio of 75.84, a PEG ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the prior year, the firm earned $1.84 EPS. The firm’s revenue was up 22.9% on a year-over-year basis. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, insider Gary S. Guthart sold 28,800 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the completion of the sale, the insider owned 27,027 shares of the company’s stock, valued at $14,798,904.12. The trade was a 51.59% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Brian Edward Miller sold 3,500 shares of the stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president owned 5,758 shares in the company, valued at approximately $3,310,850. This trade represents a 37.81% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 86,804 shares of company stock valued at $48,043,866. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.